227 related articles for article (PubMed ID: 23232603)
1. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Ruffini F; Rossi S; Bergamaschi A; Brambilla E; Finardi A; Motta C; Studer V; Barbieri F; De Chiara V; Hayardeny L; Comi G; Centonze D; Martino G
Mult Scler; 2013 Jul; 19(8):1084-94. PubMed ID: 23232603
[TBL] [Abstract][Full Text] [Related]
2. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.
Gentile A; Musella A; De Vito F; Fresegna D; Bullitta S; Rizzo FR; Centonze D; Mandolesi G
J Neuroinflammation; 2018 Jan; 15(1):5. PubMed ID: 29304807
[TBL] [Abstract][Full Text] [Related]
3. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Thöne J; Ellrichmann G; Seubert S; Peruga I; Lee DH; Conrad R; Hayardeny L; Comi G; Wiese S; Linker RA; Gold R
Am J Pathol; 2012 Jan; 180(1):267-74. PubMed ID: 22152994
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
5. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
[TBL] [Abstract][Full Text] [Related]
6. Insight into the mechanism of laquinimod action.
Brück W; Wegner C
J Neurol Sci; 2011 Jul; 306(1-2):173-9. PubMed ID: 21429524
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
8. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
9. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Wegner C; Stadelmann C; Pförtner R; Raymond E; Feigelson S; Alon R; Timan B; Hayardeny L; Brück W
J Neuroimmunol; 2010 Oct; 227(1-2):133-43. PubMed ID: 20684995
[TBL] [Abstract][Full Text] [Related]
10. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Parodi B; Rossi S; Morando S; Cordano C; Bragoni A; Motta C; Usai C; Wipke BT; Scannevin RH; Mancardi GL; Centonze D; Kerlero de Rosbo N; Uccelli A
Acta Neuropathol; 2015 Aug; 130(2):279-95. PubMed ID: 25920452
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
12. Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Aharoni R; Saada R; Eilam R; Hayardeny L; Sela M; Arnon R
J Neuroimmunol; 2012 Oct; 251(1-2):14-24. PubMed ID: 22749337
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod.
Mishra MK; Wang J; Silva C; Mack M; Yong VW
Am J Pathol; 2012 Aug; 181(2):642-51. PubMed ID: 22749771
[TBL] [Abstract][Full Text] [Related]
14. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
Kaye J; Piryatinsky V; Birnberg T; Hingaly T; Raymond E; Kashi R; Amit-Romach E; Caballero IS; Towfic F; Ator MA; Rubinstein E; Laifenfeld D; Orbach A; Shinar D; Marantz Y; Grossman I; Knappertz V; Hayden MR; Laufer R
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6145-E6152. PubMed ID: 27671624
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
[TBL] [Abstract][Full Text] [Related]
17. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod enhances central nervous system barrier functions.
Lühder F; Kebir H; Odoardi F; Litke T; Sonneck M; Alvarez JI; Winchenbach J; Eckert N; Hayardeny L; Sorani E; Lodygin D; Flügel A; Prat A
Neurobiol Dis; 2017 Jun; 102():60-69. PubMed ID: 28235673
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
20. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
Prochnow N; Gold R; Haghikia A
J Neuroimmunol; 2013 Nov; 264(1-2):48-53. PubMed ID: 24090654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
